![Pepper Landson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pepper Landson is the founder of Praetego, Inc. as Chief Executive Officer, founded in 2017.
Former job at Medpace Research, Inc. as Vice President-Clinical Operations.
Education includes undergraduate degrees from Syracuse University and Marymount University.
| Companies | Position | Start |
|---|---|---|
Praetego, Inc.
 Praetego, Inc. BiotechnologyHealth Technology Engages in development of amadorin inhibitors for diabetic complications | Chief Executive Officer | 01/01/2017 |
| Companies | Position | End |
|---|---|---|
| NEPHROGENEX INC | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marymount University
 Marymount University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medpace Research, Inc.
 Medpace Research, Inc. Medical DistributorsDistribution Services Develops drugs and novel therapies for kidney diseases | Distribution Services |
Praetego, Inc.
Praetego, Inc. BiotechnologyHealth Technology Engages in development of amadorin inhibitors for diabetic complications | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
